Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

(2020) Jasper Fuk-Woo Chan et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

(2020) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

(2020) Xintian Xu et al.   Science China-Life Sciences

Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: clinical and virological findings

(2019) Yang Yang et al.   JOURNAL OF INFECTION

Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology

(2018) Steven J. Forrester et al.   PHYSIOLOGICAL REVIEWS

Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort

(2018) Ah Young Leem et al.   International Journal of Chronic Obstructive Pulmonary Disease

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

(2018) Kevin Damman et al.   JACC-Heart Failure

Clinical and immunological characteristics of human infections with H5N6 avian influenza virus

(2018) Yuhai Bi et al.   CLINICAL INFECTIOUS DISEASES

A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice

(2018) Peihua Niu et al.   Science China-Life Sciences

Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure

(2017) Milton Packer et al.   LANCET

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis

(2017) Yen-Chung Lin et al.   PLoS One

Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease

(2016) Hanna Fröhlich et al.   AMERICAN HEART JOURNAL

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

(2016) Jae-Hoon Ko et al.   JOURNAL OF INFECTION

Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension

(2015) Amit Kumar Rai et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse

(2015) YiWu Yan et al.   Science China-Life Sciences

The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes

(2015) Jing Guo et al.   Scientific Reports

Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

(2014) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients

(2014) Fengming Huang et al.   Nature Communications

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections

(2014) Zhen Zou et al.   Nature Communications

Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes

(2012) E. M. Mortensen et al.   CLINICAL INFECTIOUS DISEASES